Filamentous nerve cell inclusions in neurodegenerative diseases.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Current Opinion in Neurobiology

• Publication date

  1998-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0959-4388(98)80090-1PMID 9811617
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Degradation of Alzheimer's ß-Amyloid Protein by Human and Rat Brain Peptidases: Involvement of Insulin-Degrading Enzyme

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Mutant genes in familial Alzheimer's disease and transgenic models.

  1998cited by this paper
• Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity

  1998cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

  1998cited by this paper
• Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch

  1998cited by this paper
• The Neuropathology of a Chromosome 17-Linked Autosomal Dominant Parkinsonism and Dementia (“Pallido-Ponto-Nigral Degeneration”)

  1998cited by this paper
• LIN-12/Notch signaling: lessons from worms and flies.

  1998cited by this paper
• Nuclear access and action of notch in vivo.

  1998cited by this paper
• α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

  1998cited by this paper
• Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?

  1998cited by this paper
• Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

  1998cited by this paper
• Tau is a candidate gene for chromosome 17 frontotemporal dementia

  1998cited by this paper
• Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

  1998cited by this paper
• Effect of heparin on phosphorylation site specificity of neuronal Cdc2‐like kinase

  1998cited by this paper
• Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

  1998cited by this paper
• Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy

  1998cited by this paper
• Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation

  1998cited by this paper
• Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients.

  1998cited by this paper
• Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene.

  1998cited by this paper
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1

  1998cited by this paper
• Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies

  1998cited by this paper
• Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

  1998cited by this paper
• Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.

  1998cited by this paper
• Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.

  1998cited by this paper
• Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

  1998cited by this paper
• Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?

  1998cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes*

  1998cited by this paper
• Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.

  1998cited by this paper
• alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

  1998cited by this paper
• Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?

  1998cited by this paper
• α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

  1998cited by this paper
• Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

  1998cited by this paper
• Progressive supranuclear gaze palsy is in linkage disequilibrium with theτ and not the α-synuclein gene

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Frequency of stages of Alzheimer-related lesions in different age categories.

  1997cited by this paper
• Observation of metastable Abeta amyloid protofibrils by atomic force microscopy.

  1997cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997cited by this paper
• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

  1997cited by this paper
• Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.

  1997cited by this paper
• Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells

  1997cited by this paper
• Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides

  1997cited by this paper
• Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42*

  1997cited by this paper
• Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse.

  1997cited by this paper
• Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

  1997cited by this paper
• Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3*

  1997cited by this paper
• Amyloid, the presenilins and Alzheimer's disease.

  1997cited by this paper
• Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

  1997cited by this paper
• Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases

  1997cited by this paper
• Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons

  1997cited by this paper
• Role of glycosaminoglycans in determining the helicity of paired helical filaments.

  1997cited by this paper
• Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse

  1997cited by this paper
• MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.

  1997cited by this paper
• Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

  1997cited by this paper
• Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

  1997cited by this paper
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.

  1997cited by this paper
• Observation of metastable Aβ amyloid protofibrils by atomic force microscopy

  1997cited by this paper
• Immunocytochemical Co‐localization of the Proteasome in Ubiquitinated Structures in Neurodegenerative Diseases and the Elderly

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans

  1997cited by this paper
• Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases

  1997cited by this paper
• Stress‐Activated Protein Kinase/c‐Jun N‐Terminal Kinase Phosphorylates τ Protein

  1997cited by this paper
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• The Neurofibrillary Pathology of Alzheimer's Disease

  1997cited by this paper
• NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

  1997cited by this paper
• Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.

  1997cited by this paper
• Pick’s disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment

  1996cited by this paper
• Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction.

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles

  1996cited by this paper
• Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

  1996cited by this paper
• Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction

  1996cited by this paper
• Neuropathology of Parkinson's Disease

  1996cited by this paper
• NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.

  1996cited by this paper
• RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments

  1996cited by this paper
• Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform.

  1995cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995cited by this paper
• The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology.

  1994cited by this paper
• Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.

  1994cited by this paper
• Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22.

  1994cited by this paper
• Alzheimer's β‐amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

  1994cited by this paper
• Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• The Molecular and Genetic Basis of Neurological Disease

  1993cited by this paper
• Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

  1991cited by this paper
• A large kindred with autosomal dominant Parkinson's disease

  1990cited by this paper

• Application of Neurotrophic Factors as a Therapeutic Approach for Neurodegenerative Diseases

  2025cites this paper
• Establishment and Characterization of Behavioral Changes in the Nuclear Localization Human α-Synuclein Transgenic Mice

  2025cites this paper
• FcγRIIb Exacerbates LPS-Induced Neuroinflammation by Binding with the Bridging Protein DAP12 and Promoting the Activation of PI3K/AKT Signaling Pathway in Microglia

  2024cites this paper
• Current insights and assumptions on α-synuclein in Lewy body disease

  2024cites this paper
• The hormesis principle of neuroplasticity and neuroprotection.

  2024cites this paper
• Association between Parkinson’s Disease and Cancer: New Findings and Possible Mediators

  2024cites this paper
• From sleep to cancer to neurodegenerative disease: the crucial role of Hsp70 in maintaining cellular homeostasis and potential therapeutic implications

  2023cites this paper
• Mixed pathology as a rule, not exception: Time to reconsider disease nosology.

  2023cites this paper
• Amyloids on Membrane Interfaces: Implications for Neurodegeneration

  2022cites this paper
• Illustrated etiopathogenesis of Huntington's disease

  2022cites this paper
• Exploring the journey of emodin as a potential neuroprotective agent: Novel therapeutic insights with molecular mechanism of action.

  2022cites this paper
• Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson’s Disease Patient-Specific Dopamine Neurons

  2021cites this paper
• Amyloid aggregation and secondary structure changes of liver cystatin: Acidic denaturation and TFE induced studies

  2021cites this paper
• Changes in the Oligodendrocyte Progenitor Cell Proteome with Ageing

  2020cites this paper
• The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives

  2020cites this paper
• AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson’s disease

  2019cites this paper
• Creatine Supplement Effect Similar in Rotenone Induced and Transgenic PD Flies in Drosophila Melanogaster

  2019cites this paper
• Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies

  2019cites this paper
• Intravenous Immunoglobulin for Patients With Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2019cites this paper
• Evaluation of Neuroprotective effect of medicinal plants in Drosophila melanogaster model

  2018cites this paper
• Multiple System Atrophy: Many Lessons from the Transcriptome

  2018cites this paper
• 2 Genetics of Parkinson Disease

  2018cites this paper
• Molecular Biology of Dementia with Lewy Bodies

  2017cites this paper
• TiO2 Nanoparticles as Potential Promoting Agents of Fibrillation of α-Synuclein, a Parkinson's Disease-Related Protein.

  2017cites this paper
• Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

  2016cites this paper
• Untangling the Manganese-α-Synuclein Web

  2016cites this paper
• How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?

  2016cites this paper
• Spontaneous Self-Assembly of Fully Protected Ester 1:1 [α/α-Nα-Bn-hydrazino] Pseudodipeptides into a Twisted Parallel β-Sheet in the Crystal State.

  2016cites this paper
• Effect of O-Linked Glycosylation on the Equilibrium Structural Ensemble of Intrinsically Disordered Polypeptides.

  2015cites this paper
• Glial Tau Pathology in Tauopathies: Functional Consequences

  2015cites this paper
• Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies

  2015cites this paper
• Ubiquitin–proteasome system involvement in Huntington’s disease

  2014cites this paper
• Photophysical study of a π-stacked β-sheet nanofibril forming peptide bolaamphiphile hydrogel

  2014cites this paper
• iTRAQ-based quantitative proteomics study on the neuroprotective effects of extract of Acanthopanax senticosus harm on SH-SY5Y cells overexpressing A53T mutant α-synuclein.

  2014cites this paper
• Valeriana officinalis attenuates the rotenone-induced toxicity in Drosophila melanogaster.

  2013cites this paper
• Predicting fates in models of neurodegenerative disease: longitudinal measures of protein homeostasis in live neurons

  2013cites this paper
• Neuropathologic analysis of Lewy‐related α‐synucleinopathy in olfactory mucosa

  2013cites this paper
• Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions.

  2013cites this paper
• Amyloid Peptide Self-Assembly in Protic Ionic Liquids

  2013cites this paper
• Protein Quality Control in Neurodegenerative Diseases

  2013cites this paper
• Differentiation of alzheimer's disease dementia, mild cognitive impairment and normal condition using PET-FDG and AV-45 imaging : a machine-learning approach

  2013cites this paper
• Molecular events during the induction of neurodegeneration and memory loss in estrogen-deficient rats.

  2013cites this paper
• Epitopes, aggregation and membrane binding: investigating the protein structure-function relationship

  2012cites this paper
• Approaches in the treatment of Parkinson's disease: A focus on stem cell-based therapies

  2012cites this paper
• Evidence for the existence of a secondary pathway for fibril growth during the aggregation of tau.

  2012cites this paper
• The chaperone activity of α‐synuclein: Utilizing deletion mutants to map its interaction with target proteins

  2012cites this paper
• Functional Study of the Threonine Phosphorylation and the Transcriptional Coactivator Role of P68 RNA Helicase

  2012cites this paper
• Ablation of inducible nitric oxide synthase does not alter Alzheimer's like pathology in transgenic mice

  2012cites this paper
• Tau Oligomers Impair Artificial Membrane Integrity and Cellular Viability*

  2012cites this paper
• 2 Genetics of Parkinson Disease

  2012cites this paper
• Investigation of the dual cyto-toxic/-protective roles of α-synuclein in human neuroblastoma, sh-sy5y and human melanoma,sk-mel28 cells

  2011cites this paper
• Enhancement of native and phosphorylated TDP‐43 immunoreactivity by proteinase K treatment following autoclave heating

  2011cites this paper
• Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease

  2011cites this paper
• Pros and cons of a prion-like pathogenesis in Parkinson's disease

  2011cites this paper
• Understanding the Kinetic Roles of the Inducer Heparin and of Rod-like Protofibrils during Amyloid Fibril Formation by Tau Protein*

  2011cites this paper
• Proteomic modification in gills and brains of medaka fish (Oryzias melastigma) after exposure to a sodium channel activator neurotoxin, brevetoxin-1.

  2011cites this paper
• Oxidative Stress and Alzheimer Disease: Mechanisms and Therapeutic Opportunities

  2011cites this paper
• Chapter 9 – Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders

  2011cites this paper
• Study on effect of α-Synuclein enhanced survival rate of rat primary cultured neuron

  2011cites this paper
• P25α / TPPP expression increases plasma membrane presentation of the dopamine transporter and enhances cellular sensitivity to dopamine toxicity

  2011cites this paper
• Neuropathology in Mice Expressing Mouse Alpha-Synuclein

  2011cites this paper
• Genetics of Parkinson Disease

  2011cites this paper
• Pre-aggregated Aβ1–42 peptide increases tau aggregation and hyperphosphorylation after short-term application

  2011cites this paper
• Milestones in PD genetics

  2011cites this paper
• Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects.

  2010cites this paper
• Hsp70 molecular chaperones and Parkinson's disease.

  2010cites this paper
• Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditions.

  2010cites this paper
• and Alzheimer's disease

  2010cites this paper
• Development of a grape seed polyphenolic extract with anti‐oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies

  2010cites this paper
• Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases.

  2010cites this paper
• Spatially pathogenic forms of tau detected in Alzheimer's disease brain tissue by fluorescence lifetime-based Förster resonance energy transfer.

  2010cites this paper
• Molecular mechanisms of regeneration in Alzheimer's disease brain

  2010cites this paper
• Amyloid-Like Aggregates of the Yeast Prion Protein Ure2 Enter Vertebrate Cells by Specific Endocytotic Pathways and Induce Apoptosis

  2010cites this paper
• alzheimer ’ s disease and other dementias

  2010cites this paper
• Novel Proteins in α-Synucleinopathies

  2009cites this paper
• Protein conformational pathology in Alzheimer's and other neurodegenerative diseases; new targets for therapy.

  2009cites this paper
• Argyrophilic grain disease: an update about a frequent cause of dementia

  2009cites this paper
• Amyloid Fibrils – Self-Assembling Proteins

  2009cites this paper
• Mendelian forms of Parkinson's disease.

  2009cites this paper
• The proteasomal system.

  2009cites this paper
• PAMAM dendrimers as potential agents against fibrillation of alpha-synuclein, a Parkinson's disease-related protein.

  2009cites this paper
• Small Heat Shock Proteins and the Cytoskeleton

  2009cites this paper
• The mechanism of amyloid‐fibril formation by stefin B: Temperature and protein concentration dependence of the rates

  2009cites this paper
• Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1.

  2009cites this paper
• Iron , α-synuclein and Autophagy in Parkinson ’ s Disease

  2009cites this paper
• Phosphorylated TDP-43 in frontotemporal lobar degeneration and ALS

  2009cites this paper
• Molecular pathogenesis of Parkinson disease: insights from genetic studies

  2009cites this paper
• Factors patogènics convergents en taupaties

  2009cites this paper
• Non-toxic concentrations of α-synuclein exacerbate Parkinson's disease-like cell death by inducing mitochondrial dysfunction

  2008cites this paper
• Tau isoform expression and regulation in human cortical neurons

  2008cites this paper
• The Cytoskeleton in Oligodendrocytes

  2008cites this paper
• Dequalinium-Induced Cell Death of Yeast Expressing α-Synuclein-GFP Fusion Protein

  2008cites this paper
• The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease.

  2008cites this paper
• Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

  2008cites this paper
• RNA profiling in an Alzheimer's disease mouse model

  2008influential citation
• Mitogen‐activated protein kinase activity may not be necessary for the neuropathology of Niemann–Pick type C mice

  2008cites this paper
• Disintegration of amyloid fibrils of alpha-synuclein by dequalinium.

  2008cites this paper
• Argyrophilic grain disease.

  2008cites this paper
• Intrinsically disordered proteins in human diseases: introducing the D2 concept.

  2008cites this paper
• Effects of in vivo treatment with diphenyl ditelluride on the phosphorylation of cytoskeletal proteins in cerebral cortex and hippocampus of rats.

  2008cites this paper